Delivery Order SPE2DR25D2208-SPE2DR26FB4TR
- Not listed
- The Defense Logistics Agency awarded a $3,336.89 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Linzess 145 microgram capsules (30-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of December 3, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Linzess 290 microgram capsules (30-count units) with a ceiling value of $6,596.11. This is a firm fixed price delivery order issued under a competitive, non-set-aside procurement. The order is set for ultimate completion on December 23, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $1,332.48 delivery order to AmerisourceBergen Drug Corp for 30 capsules of Linzess 72 micrograms on December 16, 2025, with completion scheduled for December 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $11,335.78 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Linzess 290 microgram capsules in quantities of 30 units. This firm fixed-price contract represents a competitively awarded, non-set-aside procurement with a completion date of August 19, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $2,386.99 for the supply of Linzess 145 mcg capsules (30-unit quantity) with an ultimate completion date of August 5, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $2,759.16 to supply 30 capsules of Linzess 145 micrograms. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of December 1, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Linzess 290 mcg capsules (30-count units) with a ceiling value of $43,043.86. This firm fixed-price delivery order, with an ultimate completion date of December 3, 2025, was competitively awarded without set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its...
- The Defense Logistics Agency awarded a delivery order valued at $4,736.39 to AmerisourceBergen Drug Corp for the supply of Linzess 145 mcg capsules (30-count units) on November 6, 2025, with completion scheduled for November 7, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $1,909.80 to AmerisourceBergen Drug Corp for Linzess 72 microgram capsules (30-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This competitive award, which carries no set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in...
- The Defense Logistics Agency awarded a $1,711.90 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Linzess 145 microgram capsules (30-count units). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate...
- SPE2DR25D2208Indefinite Delivery Contract
- SPE2DR25D2208-SPE2DR26FB4TRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,575.46 to AmerisourceBergen Drug Corp for 30 capsules of Linzess 145 micrograms on December 23, 2025, with completion expected by December 24, 2025. This firm fixed-price delivery order represents a competitively awarded transaction with no set-aside designation. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters and primary operations supporting federal medical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The IDC enables AmerisourceBergen to supply a wide range of pharmaceuticals, medical supplies, vaccines, and specialized medical commodities to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen leverages this prime contract vehicle to fulfill ongoing medical supply needs across the Defense Department's healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 12/22/25 |